Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8118802 | FRESENIUS KABI USA | Connector for packaging containing medical fluids and packaging for medical fluids |
May, 2023
(3 months from now) | |
US8162915 | FRESENIUS KABI USA | Connector for packings containing medical liquids, and corresponding packing for medical liquids |
May, 2024
(1 year, 3 months from now) | |
US7828787 | FRESENIUS KABI USA | Connector for packaging containing medical fluids and packaging for medical fluids |
Oct, 2025
(2 years from now) | |
US7857802 | FRESENIUS KABI USA | Connector for medical liquid-containing packages and medical liquid-containing packages |
Nov, 2026
(3 years from now) |
Market Authorisation Date: 24 September, 1996
Treatment: NA
Dosage: SOLUTION;INJECTION
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic